Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × zimberelimab × 90 days × Clear all

Sponsor

Conditions

Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Carcinoma, Renal Cell 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Kidney Neoplasms 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Glioblastoma 1 Esophageal Neoplasms 1 Erythrocytosis, Familial, 4 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Bile Duct Neoplasms 1 Advanced Solid Tumor 1

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡